Human rhinovirus 16 infection of human macrophages disrupts Arpin expression impairing macrophage internalization: a potential link to exacerbation in chronic obstructive pulmonary disease?

J. Jubrail (Edinburgh, United Kingdom), K. Africano Gomez (Paris, France), F. Herit (Paris, France), A. Mularski (Paris, France), P. Bourdoncle (Paris, France), L. Oberg (Gothenburg, Sweden), E. Israelsson (Gothenburg, Sweden), P. Regis-Burgel (Paris, France), G. Mayer (Gothenburg, Sweden), D. Cunoosamy (Massachusetts, United States of America), N. Kurian (Massachusetts, United States of America), F. Niedergang (Paris, France)

Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Session: Host-microbe interactions and their influence on lung disease onset and severity
Session type: E-poster session
Number: 1063
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Jubrail (Edinburgh, United Kingdom), K. Africano Gomez (Paris, France), F. Herit (Paris, France), A. Mularski (Paris, France), P. Bourdoncle (Paris, France), L. Oberg (Gothenburg, Sweden), E. Israelsson (Gothenburg, Sweden), P. Regis-Burgel (Paris, France), G. Mayer (Gothenburg, Sweden), D. Cunoosamy (Massachusetts, United States of America), N. Kurian (Massachusetts, United States of America), F. Niedergang (Paris, France). Human rhinovirus 16 infection of human macrophages disrupts Arpin expression impairing macrophage internalization: a potential link to exacerbation in chronic obstructive pulmonary disease?. 1063

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Human rhinovirus 16 infection of human macrophages significantly impairs their phagocytic and regulatory functions: implications in understanding chronic inflammatory lung disease
Source: International Congress 2017 – New Mechanistic Findings in COPD
Year: 2017



Characterisation of defective phagocytosis by chronic obstructive pulmonary disease alveolar macrophages
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016


Increased vimentin expression in human primary bronchial epithelium reconstituted in vitro from patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013


Human macrophage elastase (MMP-12) expression in human emphysematous lungs: role in extracellular matrix remodelling in chronic obstructive pulmonary diseases (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 501s
Year: 2001

High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients: a reflection of an enhanced immunological function
Source: Eur Respir J 2006; 28: 113-122
Year: 2006



Chronic persistence of human ?-herpesviruses and regulatory cells phenotypes in severe bronchial asthma.
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017

High dimensional single cell analysis reveals unexpected immune cell types, and loss of motility and chemokine receptor expression of alveolar macrophages in chronic obstructive respiratory disease
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018



Increased circulating fibrocytes and their capacity of proliferation and differentiation in clinically unstable patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

Genetic deletion of SLPI promotes inflammatory cell recruitment in a model of chronic lung disease
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021


Micro-RNA-125a/b target A20 and MAVS to promote inflammatory and impair antiviral responses in chronic obstructive pulmonary disease
Source: International Congress 2016 – Mechanisms of disease
Year: 2016

Upregulation of myeloid derived suppressor cells (MDSCs) in chronic obstructive pulmonary disease and its relationship with disease severity
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012

Characterization of human airway epithelial cell lines as in vitro models of chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021

IL-33 may augment the effect of rhinovirus HRV16 on the inflammatory activity of human lung vascular endothelium – possible implication for asthma exacerbations.
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021

Toll-like receptor (TLR)-signaling mediates enhanced inflammatory effects in coinfections of viral and bacterial respiratory pathogens in human lung tissue – A new approach to the pathogenesis of COPD exacerbations?
Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Year: 2011

The TLR5 agonist flagellin prevents bacteria-induced chronic obstructive pulmonary disease exacerbations in mice.
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017



Enhanced expression of IL-18 receptor but not soluble form of IL18R in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011

Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009

Impact of chronic bronchial infection on the lungs and beyond
Source: Eur Respir Monogr 2013; 60: 46-57
Year: 2013


Relationship between monocyte-derived macrophage phagocytosis and airway inflammation in stable COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013


Exacerbations of chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 29: 1224-1238
Year: 2007